Unknown

Dataset Information

0

The phosphatidylethanolamine derivative diDCP-LA-PE mimics intracellular insulin signaling.


ABSTRACT: Insulin facilitates glucose uptake into cells by translocating the glucose transporter GLUT4 towards the cell surface through a pathway along an insulin receptor (IR)/IR substrate 1 (IRS-1)/phosphatidylinositol 3 kinase (PI3K)/3-phosphoinositide-dependent protein kinase-1 (PDK1)/Akt axis. The newly synthesized phosphatidylethanolamine derivative 1,2-O-bis-[8-{2-(2-pentyl-cyclopropylmethyl)-cyclopropyl}-octanoyl]-sn-glycero-3-phosphatidylethanolamine (diDCP-LA-PE) has the potential to inhibit protein tyrosine phosphatase 1B (PTP1B) and to directly activate PKCζ, an atypical isozyme, and PKCε, a novel isozyme. PTP1B inhibition enhanced insulin signaling cascades downstream IR/IRS-1 by preventing tyrosine dephosphorylation. PKCζ and PKCε directly activated Akt2 by phosphorylating at Thr309 and Ser474, respectively. diDCP-LA-PE increased cell surface localization of GLUT4 and stimulated glucose uptake into differentiated 3T3-L1 adipocytes, still with knocking-down IR or in the absence of insulin. Moreover, diDCP-LA-PE effectively reduced serum glucose levels in type 1 diabetes (DM) model mice. diDCP-LA-PE, thus, may enable type 1 DM therapy without insulin injection.

SUBMITTER: Nishizaki T 

PROVIDER: S-EPMC4890120 | biostudies-other | 2016

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC9626938 | biostudies-literature
| S-EPMC2649265 | biostudies-literature
| S-EPMC11332076 | biostudies-literature
| S-EPMC3351361 | biostudies-literature
| S-EPMC5916947 | biostudies-literature
| S-EPMC3871175 | biostudies-literature
| S-EPMC5715112 | biostudies-literature
| S-EPMC8132115 | biostudies-literature
| S-EPMC5167783 | biostudies-literature
| S-EPMC1147318 | biostudies-other